Literature DB >> 12584306

Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.

Sybil M Genther1, Stephanie Sterling, Stefan Duensing, Karl Münger, Carol Sattler, Paul F Lambert.   

Abstract

Human papillomaviruses (HPVs) are small circular DNA viruses that cause warts. Infection with high-risk anogenital HPVs, such as HPV type 16 (HPV16), is associated with human cancers, specifically cervical cancer. The life cycle of HPVs is intimately tied to the differentiation status of the host epithelium and has two distinct stages: the nonproductive stage and the productive stage. In the nonproductive stage, which arises in the poorly differentiated basal epithelial compartment of a wart, the virus maintains itself as a low-copy-number nuclear plasmid. In the productive stage, which arises as the host cell undergoes terminal differentiation, viral DNA is amplified; the capsid genes, L1 and L2, are expressed; and progeny virions are produced. This stage of the viral life cycle relies on the ability of the virus to reprogram the differentiated cells to support DNA synthesis. Papillomaviruses encode multiple oncoproteins, E5, E6, and E7. In the present study, we analyze the role of one of these viral oncogenes, E5, in the viral life cycle. To assess the role of E5 in the HPV16 life cycle, we introduced wild-type (WT) or E5 mutant HPV16 genomes into NIKS, a keratinocyte cell line that supports the papillomavirus life cycle. By culturing these cells under conditions that allow them to remain undifferentiated, a state similar to that of basal epithelial cells, we determined that E5 does not play an essential role in the nonproductive stage of the HPV16 life cycle. To determine if E5 plays a role in the productive stage of the viral life cycle, we cultured keratinocyte populations in organotypic raft cultures, which promote the differentiation and stratification of epithelial cells. We found that cells harboring E5 mutant genomes displayed a quantitative reduction in the percentage of suprabasal cells undergoing DNA synthesis, compared to cells containing WT HPV16 DNA. This reduction in DNA synthesis, however, did not prevent amplification of viral DNA in the differentiated cellular compartment. Likewise, late viral gene expression and the perturbation of normal keratinocyte differentiation were retained in cells harboring E5 mutant genomes. These data demonstrate that E5 plays a subtle role during the productive stage of the HPV16 life cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584306      PMCID: PMC149772          DOI: 10.1128/jvi.77.5.2832-2842.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.

Authors:  J T Schiller; W C Vass; K H Vousden; D R Lowy
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity.

Authors:  D DiMaio; D Guralski; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes.

Authors:  S Duensing; A Duensing; E R Flores; A Do; P F Lambert; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide.

Authors:  R Schlegel; M Wade-Glass; M S Rabson; Y C Yang
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

8.  Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes.

Authors:  P Tomakidi; H Cheng; A Kohl; G Komposch; A Alonso
Journal:  Eur J Cell Biol       Date:  2000-06       Impact factor: 4.492

9.  Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.

Authors:  M I Rodríguez; M E Finbow; A Alonso
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

10.  The human papillomavirus type 16 E5 protein alters vacuolar H(+)-ATPase function and stability in Saccharomyces cerevisiae.

Authors:  M W Briggs; J L Adam; D J McCance
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

View more
  79 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 2.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  A role for HPV16 E5 in cervical carcinogenesis.

Authors:  John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

5.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

Authors:  Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Authors:  Lulin Hu; Kendra Plafker; Valeriya Vorozhko; Rosemary E Zuna; Marie H Hanigan; Gary J Gorbsky; Scott M Plafker; Peter C Angeletti; Brian P Ceresa
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

8.  E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.

Authors:  Erin Isaacson Wechsler; Sharof Tugizov; Rossana Herrera; Maria Da Costa; Joel M Palefsky
Journal:  J Gen Virol       Date:  2018-04-06       Impact factor: 3.891

Review 9.  Role of Zn2+ ions in host-virus interactions.

Authors:  Maciej Lazarczyk; Michel Favre
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.